How APOA2 Genotype Modulates Saturated Fat Effects on Body Weight
The CC variant at rs5082 changes how your body processes saturated fat through gene expression, not just calorie counting.
The APOA2 gene produces a protein involved in lipid metabolism. Research indicates that the rs5082 variant interacts with dietary saturated fat to influence body weight. The mechanism is specific to how the gene is expressed under certain dietary conditions.
What APOA2 does
A 2018 study in the American Journal of Clinical Nutrition examined the molecular basis for the APOA2-saturated fat interaction. The researchers found that CC carriers consuming a high-saturated fat diet (≥22 g/day) had significantly lower APOA2 mRNA expression in the blood compared to TT carriers on the same diet.
This reduction in expression was linked to specific methylation changes at the cg04436964 site in the APOA2 regulatory region. The study validated these findings across multiple cohorts, including the Boston Puerto Rican Health Study, the GOLDN study, and the Framingham Heart Study. The epigenetic shift appears to be the driver for the observed differences in body weight metrics associated with high saturated fat intake.
Your variants, decoded
A promoter variant that alters how saturated fat intake influences APOA2 gene expression and body weight regulation.
| CC | Higher body weight risk specifically when saturated fat intake is high; epigenetic changes reduce APOA2 expression. |
| CT | Intermediate response; effects depend on specific saturated fat levels. |
| TT | Lower body weight risk relative to CC carriers when saturated fat intake is high; maintains higher APOA2 expression under high SFA conditions. |
We show genotypes on the forward strand and ignore letter order. Your own export may print the complementary letters. Same result either way.
What the research suggests
The research shows that CC carriers of the APOA2 rs5082 variant have lower gene expression when eating a lot of saturated fat due to specific DNA methylation changes. This biological mechanism explains why those individuals tend toward higher body weight under those specific dietary conditions. The practical move is to moderate saturated fat intake rather than assuming the gene dictates your weight regardless of diet.
PubMed 29901700 · APOA2 rs5082 CC carriers showed lower APOA2 expression and higher obesity risk on high-saturated-fat diets (Am J Clin Nutr, 2018).
Educational only, not medical advice. “General evidence” means the finding is real, but the benefit isn’t specific to your genotype.
See this matched to your own DNA, free.
Upload your 23andMe or AncestryDNA file and you'll get your actual APOA2 result, plus every other variant worth acting on. Every line cited. Your file is never stored.
Questions
Does eating saturated fat make me gain weight if I have the CC genotype?
The 2018 study (PMID 29901700) found that CC carriers had lower APOA2 expression and altered amino acid metabolism specifically when consuming a high saturated fat diet (≥22 g/day). This suggests the weight risk is tied to high saturated fat intake, not just the gene variant alone.
Is this gene interaction proven to cause obesity directly?
The study identifies a mechanism linking the CC genotype, high saturated fat intake, reduced APOA2 expression, and metabolic pathway changes. It shows an association and a plausible biological mechanism, but does not prove direct causation of obesity in all individuals.